Naotake Tsuda
About
Naotake Tsuda is a scholar working on Immunology, Oncology and Molecular Biology.
According to data from OpenAlex, Naotake Tsuda has authored 66 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Immunology, 24 papers in Oncology and 18 papers in Molecular Biology. Recurrent topics in Naotake Tsuda's work include Immunotherapy and Immune Responses (28 papers), Cancer Immunotherapy and Biomarkers (11 papers) and Endometrial and Cervical Cancer Treatments (9 papers). Naotake Tsuda is often cited by papers focused on Immunotherapy and Immune Responses (28 papers), Cancer Immunotherapy and Biomarkers (11 papers) and Endometrial and Cervical Cancer Treatments (9 papers). Naotake Tsuda collaborates with scholars based in Japan, United States and Slovakia. Naotake Tsuda's co-authors include Kouichiro Kawano, Kimio Ushijima, Akira Yamada, Toshiharu Kamura, Constantin G. Ioannides, Shigeki Shichijo, Kyogo Itoh, Clay L. Efferson, Shin Nishio and Hideaki Yamana and has published in prestigious journals such as The Journal of Immunology, Cancer Research and Journal of Virology.
In The Last Decade
Naotake Tsuda
63 papers receiving 1.3k citations
Peers
Naotake Tsuda
J O’Connell Ireland
Jung‐Joo Choi South Korea
Fenge Li China
Heather L. LaMarca United States
Ilaria Grazia Zizzari Italy
G E Hannigan Canada
Bellinda A. Bladergroen Netherlands
Renske Goedemans Netherlands
Fang Xiong China
Guitta Maki France
Citations per year, relative to Naotake Tsuda Naotake Tsuda (= 1×)
peers
J O’Connell
Countries citing papers authored by Naotake Tsuda
Since
Specialization
Citations
This map shows the geographic impact of Naotake Tsuda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naotake Tsuda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naotake Tsuda more than expected).
Fields of papers citing papers by Naotake Tsuda
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Naotake Tsuda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naotake Tsuda. The network helps show where Naotake Tsuda may publish in the future.
Co-authorship network of co-authors of Naotake Tsuda
This figure shows the co-authorship network connecting the top 25 collaborators of Naotake Tsuda. A scholar is included among the top collaborators of Naotake Tsuda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naotake Tsuda. Naotake Tsuda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Ogo, Etsuyo, et al.. (2024). Effective timing of hyaluronate gel injection in image-guided adaptive brachytherapy for uterine cervical cancer: a proposal of the ‘adjusted dose score’. Journal of Radiation Research. 65(3). 393–401.
2.
Sanada, Sakiko, Sachiko Ogasawara, Naotake Tsuda, et al.. (2024). CXCR4 Expression and Cancer-associated Fibroblasts May Play an Important Role in the Invasion of Low-grade Endometrioid Carcinoma. International Journal of Gynecological Pathology. 43(6). 557–564.
3.
Nishio, Shin, et al.. (2024). Olaparib maintenance therapy for platinum‐sensitive relapsed ovarian cancer at a single institution: A retrospective study. Journal of obstetrics and gynaecology research. 50(7). 1192–1200.
4.
Mihara, Yutaro, et al.. (2024). Granulomatous mastitis during pregnancy with sudden onset of gait difficulty and erythema nodosum: A case report and review of the literature. Journal of obstetrics and gynaecology research. 50(10). 1985–1989.
5.
Nishio, Shin, et al.. (2023). Association of Chemotherapy Response Score with Multidrug Resistance 1 and CA125 ELIMination Rate Constant K in Patients with Advanced Ovarian Cancer Treated with Neoadjuvant Chemotherapy. The Kurume Medical Journal. 70(1.2). 29–37.
6.
Ushijima, Kimio, Naotake Tsuda, Wataru Yamagami, et al.. (2023). Trends and characteristics of fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer in Japan: a survey by the Gynecologic Oncology Committee of the Japan Society of Obstetrics and Gynecology. Journal of Gynecologic Oncology. 34(3). e38–e38.
7.
Ogo, Etsuyo, Toshi Abe, Naotake Tsuda, et al.. (2023). Dynamics in the expression of programmed death ligand 1 and cluster of differentiation 163 in the tumor microenvironment of uterine cervical cancer: a single-center retrospective study. Radiation Oncology. 18(1). 40–40.
8.
Tsuda, Naotake, et al.. (2023). Development and application of a large‐scale disaster preparedness system in the perinatal field. International Journal of Gynecology & Obstetrics. 162(1). 333–338.
9.
Tsuda, Naotake, Shin Nishio, Tomohiko Yamaguchi, et al.. (2022). N-Myc Downstream Regulated Gene-1 May Play an Important Role in the Prognosis of Ovarian Cancer, in Its Association with Beta-Catenin. The Kurume Medical Journal. 69(1.2). 39–46.
10.
Nishio, Shin, et al.. (2022). Comprehensive Molecular Profiling and Clinicopathological Characteristics of Gastric-Type Mucinous Carcinoma of the Uterine Cervix in Japanese Women. The Kurume Medical Journal. 69(3.4). 237–249.
11.
Nishio, Shin, et al.. (2018). A phase II trial of irinotecan in patients with advanced or recurrent endometrial cancer and correlation with biomarker analysis. Gynecologic Oncology. 150(3). 432–437.
12.
Nishio, Shin, Munetaka Takekuma, Satoshi Takeuchi, et al.. (2017). Phase 1 study of veliparib with carboplatin and weekly paclitaxel in Japanese patients with newly diagnosed ovarian cancer. Cancer Science. 108(11). 2213–2220.
13.
Li, Yufeng, Satoko Matsueda, Naotake Tsuda, et al.. (2009). Distinct patient responses to activation of T-cells by free HER-2, G89 (777-789) and protected LRMK-linked HER-2, {AE-39 [p776 (Ava-774-788)], AE-47 [(Ava-776-788)] and AE-37[p776 (774-788)]} peptides could lead to development of personalized cancer vaccines.. PubMed. 29(1). 41–58.
14.
Ioannides, Constantin G., Satoshi Ishiyama, Satoko Matsueda, Naotake Tsuda, & Yufeng Li. (2008). HER-2 peptides p776 and F7, N-terminal-linked with Ii-Key tetramer (LRMK) help the proliferation of E75-TCR+ cells: The dependency of help on the side chains of LRMK-extended peptide pointed towards the T cell receptor. Oncology Reports. 19(6). 1445–52.
15.
Tsuda, Naotake, David Z. Chang, Takashi Mine, et al.. (2007). Taxol Increases the Amount and T Cell–Activating Ability of Self-Immune Stimulatory Multimolecular Complexes Found in Ovarian Cancer Cells. Cancer Research. 67(17). 8378–8387.
16.
Tsuda, Naotake, Satoshi Ishiyama, Yufeng Li, et al.. (2006). Synthetic MicroRNA Designed to Target Glioma-Associated Antigen 1 Transcription Factor Inhibits Division and Induces Late Apoptosis in Pancreatic Tumor Cells. Clinical Cancer Research. 12(21). 6557–6564.
17.
Efferson, Clay L., Kouichiro Kawano, Naotake Tsuda, et al.. (2005). Stimulation of human T cells by an influenza A vector expressing a CTL epitope from the HER-2/neu protooncogene results in higher numbers of antigen-specific TCRhi cells than stimulation with peptide. Divergent roles of IL-2 and IL-15.. PubMed. 25(2A). 715–24.
18.
Nonaka, Yoichi, Naotake Tsuda, Shigeki Shichijo, et al.. (2002). Recognition of ADP‐ribosylation factor 4‐like by HLA‐A2‐restricted and tumor‐reactive cytotoxic T lymphocytes from patients with brain tumors. Tissue Antigens. 60(4). 319–327.
19.
Nakao, Masanobu, Shigeki Shichijo, Toshihiro Imaizumi, et al.. (2000). Identification of a Gene Coding for a New Squamous Cell Carcinoma Antigen Recognized by the CTL. The Journal of Immunology. 164(5). 2565–2574.
20.
Tanaka, Shoko, Naotake Tsuda, Masaru Sakamoto, et al.. (2000). Expression of Tumor‐rejection Antigens in Gynecologic Cancers. Japanese Journal of Cancer Research. 91(11). 1177–1184.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by J O’Connell Breakdown of academic impact, for papers by Jung‐Joo Choi Breakdown of academic impact, for papers by Fenge Li Breakdown of academic impact, for papers by Heather L. LaMarca Breakdown of academic impact, for papers by Ilaria Grazia Zizzari Breakdown of academic impact, for papers by G E Hannigan Breakdown of academic impact, for papers by Bellinda A. Bladergroen Breakdown of academic impact, for papers by Renske Goedemans Breakdown of academic impact, for papers by Fang Xiong Breakdown of academic impact, for papers by Guitta Maki